EuroPCR 2023 Hotlines/Late-Breaking Trials: from (N)STEMI to Chronic Coronary Syndromes (CCS)

Session comprising selected EuroPCR 2023 Late-Breaking Trial submissions

Anchorperson: D. Capodanno

Spokesperson: H. Amin

Summary

What are the most significant facts in this respect? Get the essentials by listening to the presenters review some clinical hotlines. To cite a few, Selective Intracoronary hypothermia in anterior wall myocardial infarction; real-time catheter-based microvascular obstruction detection in STEMI : results from the MOCCA I study; QFR vs. FFR in STEMI, a substudy of the REDUCE MVI randomised clinical trial; Immediate culprit lesion primary PCI in patients with STEMI and much more.

Presentations available when logged in:

Selective Intracoronary hypothermia in anterior wall myocardial infarction
Real-time catheter-based microvascular obstruction detection in STEMI: results from the MOCA I study
QFR vs. FFR in STEMI: a substudy of the REDUCE MVI randomised clinical trial
Immediate culprit lesion primary PCI in patients with STEMI
Extracorporeal membrane oxygenation vs. standard care in cardiogenic shock
Five-year clinical outcome of a the TIDES ACS study
Murray law-based QFR on three-year outcomes of FORZA trial
Quantitative flow ratio or angiography for the assessment of non-culprit lesions
Non-cardiac mortality with elective revascularisation vs. medical therapy

Your free My PCR account will enable you to:

Become a PCR Companion
Access slide presentations from PCR Courses
Watch session videos and LIVE cases
Discuss cases with your peers
Submit and register for PCR Courses
Register for and view PCR Webinars
Read a selection of articles in EuroIntervention
And more…

EuroPCR 2023 Hotlines/Late-Breaking Trials: from (N)STEMI to Chronic Coronary Syndromes (CCS)

Session comprising selected EuroPCR 2023 Late-Breaking Trial submissions

Log in or create account for free